<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180226038870N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-11</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>"Evaluation if weight bearing exercises on patients with knee osteoarthritis treated by stromal cells"</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of weight bearing exercises on pain and physical function of patients with knee osteoarthritis treated by implantation of autologous bone marrow derived mesenchymal stromal cells.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53400</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The method of assigning the subjects after applying the entry and exit criteria will be random allocation by permutation block method. The randomization unit is individual. The size of the blocks is 4 and in each block, each intervention group will be repeated twice. As a result, we will have 6 different blocks, each of which will be numbered from 1 to 6 as desired. Then, using the rdunif statistical program code (n = 10, b = 6, a = 1) in R software version 3.6.1, 10 blocks of 4 will be generated, which will produce a total of 40 sequences. (It should be noted that this code generates ten random numbers from the numbers 1 to 6, which are the number of blocks). Using this randomly generated list, patients will be placed in the intervention group (exercise therapy with weight bearing) and the control group (exercise therapy without weight bearing). To hide the random allocation list, a special code will be assigned to each of the intervention groups that only the main executor of the project is aware of. These codes are written on a piece of paper and placed in a sealed envelope. A unique code that is specific to each patient will be written on this paper as well as its envelope. A foil is also placed inside each envelope so that the envelopes are not legible under light. Each envelope also contains a white paper and a carbon. All envelopes are placed in a larger box in random order and will be sealed in the box. The main researcher, after reviewing the inclusion criteria and obtaining informed consent, as well as registering the patient's details in a special form, will contact the partner who has a random assignment list (except for the main researcher who is not involved in the patient recruitment and sample entry process). And the patient is randomized. Also, before opening the envelope, this person must write the name and surname and age of the person on the place marked on the envelope so that its copy falls on the paper inside the envelope, Blinding description: In this study, due to the nature of this trial, that requires exercise by volunteers, only statistical analyzer blinding will be possible, and volunteers and the evaluating physician who works with both groups of patients are not blind to it. Before the person enters the study, the physician in charge of the project will fully explain to the patient that the people will be randomly placed in each of the two groups and the patient will be fully aware of this.
Finally, the statistical analyzer whom will be blind to the data , will analyze it and will not know which treatment protocol is included for each person.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee Osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the group receiving exercises with weight bearing (group A), the exercise sessions are as follows: Aerobic exercises include: walking 3 days a week with moderate intensity for 30 minutes daily for the first 1 month, during the Second month: 40 minutes daily and finally 45 minutes daily in the last month. Type: Walking Strength training (on days when aerobic exercise is not done) Includes: For quadriceps 4 days a week with an average intensity of 5 out of 10 or until Patient to be tired. Type: Semi Scott.                                                                    To strengthen the lower limbs: 4 days a week with moderate intensity: 5 out of 10 or until tired. 30 repetitions per leg, 10 repetitions Type: Balance.                                             To strengthen the lower limbs: 4 days Medium intensity per week: 5 out of 10 or until tired. Type: cuff raise. in the first month with both feet and then as a single foot. Intervention 2: Intervention group: In the receiving group Exercise without weight bearing (group B) Exercise sessions are as follows: Aerobic: 3 days a week with moderate intensity on a scale of 5 out of 10 for 30 minutes daily for the first month, 40 minutes daily in the second month and finally 45 Minutes per day in the third month. Type: Walking in the pool.                              For resistance in days when aerobic exercise is not done. Isometric quadriceps contraction: 4 days a week with moderate intensity: 5 out of 10 or until tired. 3 sets with 8 seconds contraction with 10 repetitions Type: quadratic isometric contraction.                                                       Then to strengthen the lower limbs 4 days a week medium intensity, 5 of 10 or until he is tired. 8 seconds of contraction: 3 sets of 30 degrees of knee flexion in the prone position, and after being able to bear weight of the same leg for 8 seconds, put the opposite leg on this leg and train with the weight of both legs. . To strengthen the lower limbs 4 days a week on average: 5 out of 10 or until tired: 2 sets with 8 seconds of contraction with 10 repetitions per foot: Type: Plantar Flexion and dorsiflexion.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After the end of the study, all the data related to the study, including the main and secondary consequences, will be shared after Unidentifiable the individuals.

When:
Access starts 6 months after the results are published

To whom:
Researchers working in academic and scientific institutions

Conditions:
The released data can only be used for scientific use by other researchers, and the use of the data will be allowed only with the permission of the physician in charge of this project.

Where to obtain:
Arabi Ave, Shahid Chamran Blvd, Tehran
Mohammad Hassabi
0098 021 22432560
hassabi@yahoo.com

How to obtain:
The doctor in charge will be contacted first, after coordination with him, they will receive information via e-mail or in person at their discretion. This process will take 1 to 2 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Hassabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Arabi Ave, Shahid Chamran Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985711151</zip>
        <telephone>+98 21 2243 2560</telephone>
        <email>ddrnlz@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Hassabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Arabi Ave, Shahid Chamran Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985711151</zip>
        <telephone>+98 21 2243 2560</telephone>
        <email>hassabi@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Knee osteoarthritis of grade 2 or 3 diagnosed by MRI and confirmed by orthopedics surgeon.
Less than one month before enrollment in the present study, the patient underwent intra-knee implantation of bone marrow-derived mesenchymal stromal cells.
Aged between 18-65 years old.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Uncontrolled medical situations which need frequent medical treatment and therefore patient will be unable regularly participate in follow up sessions of current trial, such as cancers and autoimmune diseases.
Pregnancy and lactating</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the group receiving exercises with weight bearing (group A), the exercise sessions are as follows: Aerobic exercises include: walking 3 days a week with moderate intensity for 30 minutes daily for the first 1 month, during the Second month: 40 minutes daily and finally 45 minutes daily in the last month. Type: Walking Strength training (on days when aerobic exercise is not done) Includes: For quadriceps 4 days a week with an average intensity of 5 out of 10 or until Patient to be tired. Type: Semi Scott.                                                                    To strengthen the lower limbs: 4 days a week with moderate intensity: 5 out of 10 or until tired. 30 repetitions per leg, 10 repetitions Type: Balance.                                             To strengthen the lower limbs: 4 days Medium intensity per week: 5 out of 10 or until tired. Type: cuff raise. in the first month with both feet and then as a single foot.</i_keyword>
      <i_keyword>Intervention group: In the receiving group Exercise without weight bearing (group B) Exercise sessions are as follows: Aerobic: 3 days a week with moderate intensity on a scale of 5 out of 10 for 30 minutes daily for the first month, 40 minutes daily in the second month and finally 45 Minutes per day in the third month. Type: Walking in the pool.                              For resistance in days when aerobic exercise is not done. Isometric quadriceps contraction: 4 days a week with moderate intensity: 5 out of 10 or until tired. 3 sets with 8 seconds contraction with 10 repetitions Type: quadratic isometric contraction.                                                       Then to strengthen the lower limbs 4 days a week medium intensity, 5 of 10 or until he is tired. 8 seconds of contraction: 3 sets of 30 degrees of knee flexion in the prone position, and after being able to bear weight of the same leg for 8 seconds, put the opposite leg on this leg and train with the weight of both legs. . To strengthen the lower limbs 4 days a week on average: 5 out of 10 or until tired: 2 sets with 8 seconds of contraction with 10 repetitions per foot: Type: Plantar Flexion and dorsiflexion.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain on Visual Analogue Scale. Timepoint: Measurement of patients' pain in the knee joint according to Visual Analogue Scale criteria before the intervention and 1 month and 3 months after the intervention. Method of measurement: Pain on Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Patients physical function based on Western Ontario and McMaster Universities Osteoarthritis Index. Timepoint: Before intervention and 1 and 3 months after intervention. Method of measurement: Using  Western Ontario and McMaster Universities Osteoarthritis Index questionnaire.</sec_outcome>
      <sec_outcome>Patient walking distance. Timepoint: Before intervention and 1 and 3 months after intervention. Method of measurement: Based on the patient interview.</sec_outcome>
      <sec_outcome>Standing time. Timepoint: Before intervention and 1 and 3 months after intervention. Method of measurement: Based on the patient interview.</sec_outcome>
      <sec_outcome>Patient quality of life. Timepoint: Before intervention and 1 and 3 months after intervention. Method of measurement: The 36-Item Short Form Survey (SF-36).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-06-02</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Taleghani hospital Arabi Ave, Shahid Chamran Blvd. Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
